Cover Story
By Matthew Bin Han Ong
After an examination of the causes of an avalanche of grant applications directed at NCI, institute officials found that new applications largely come from principal investigators who are switching their research focus to cancer. No other NIH institute or center faces such pressure.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for December 2019
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.” - Trump 2016: A look back at the 45th president’s impact on oncology
- Don’t confirm RFK Jr. for HHS, 77 Nobel laureates urge the Senate
- VCU awarded $9M from NCI to establish Cancer Control Equity Research Center
- Art exhibit at University of Miami Sylvester bridges North and South America
- The Cancer Letter’s most-read stories of 2024